Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip R Spradling

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Vaccine|October 2, 2021
Prevalence of indications for adult hepatitis A vaccination among hepatitis A outbreak-associated cases, Three US States, 2016-2019Megan G Hofmeister, Mark K Weng, Douglas Thoroughman, et al.
International Journal of Circumpolar Health|May 21, 2016
Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012Prabhu P Gounder, Lisa R Bulkow, Martin I Meltzer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2006
Severe or fatal liver injury in 50 patients in the United States taking rifampin and pyrazinamide for latent tuberculosis infectionKashef Ijaz, John A Jereb, Lauren A Lambert, et al.
Hepatology (Baltimore, Md.)|February 29, 2012
Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-upUmid M Sharapov, Lisa R Bulkow, Susan E Negus, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 16, 2020
Mental and physical health status among chronic hepatitis B patientsYihe G Daida, Joseph A Boscarino, Anne C Moorman, et al.
Clinical and Vaccine Immunology : CVI|July 25, 2014
Hepatitis B virus antibody levels 7 to 9 years after booster vaccination in Alaska native personsJames W Keck, Lisa R Bulkow, Gregory A Raczniak, et al.
Vaccine|March 9, 2013
Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in childrenGregory A Raczniak, Timothy K Thomas, Lisa R Bulkow, et al.
The American Journal of Managed Care|August 17, 2019
Late diagnosis of hepatitis C virus infection, 2014-2016: continuing missed intervention opportunitiesAnne C Moorman, Jian Xing, Loralee B Rupp, et al.
Vaccine|October 22, 2011
Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilitiesRania A Tohme, Debo Awosika-Olumo, Carrie Nielsen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2021
The Persistence of Underreporting of Hepatitis C as an Underlying or Contributing Cause of Death, 2011-2017Philip R Spradling, Yuna Zhong, Anne C Moorman, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Vaccine|October 2, 2021
Prevalence of indications for adult hepatitis A vaccination among hepatitis A outbreak-associated cases, Three US States, 2016-2019Megan G Hofmeister, Mark K Weng, Douglas Thoroughman, et al.
International Journal of Circumpolar Health|May 21, 2016
Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012Prabhu P Gounder, Lisa R Bulkow, Martin I Meltzer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2006
Severe or fatal liver injury in 50 patients in the United States taking rifampin and pyrazinamide for latent tuberculosis infectionKashef Ijaz, John A Jereb, Lauren A Lambert, et al.
Hepatology (Baltimore, Md.)|February 29, 2012
Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-upUmid M Sharapov, Lisa R Bulkow, Susan E Negus, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 16, 2020
Mental and physical health status among chronic hepatitis B patientsYihe G Daida, Joseph A Boscarino, Anne C Moorman, et al.
Clinical and Vaccine Immunology : CVI|July 25, 2014
Hepatitis B virus antibody levels 7 to 9 years after booster vaccination in Alaska native personsJames W Keck, Lisa R Bulkow, Gregory A Raczniak, et al.
Vaccine|March 9, 2013
Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in childrenGregory A Raczniak, Timothy K Thomas, Lisa R Bulkow, et al.
The American Journal of Managed Care|August 17, 2019
Late diagnosis of hepatitis C virus infection, 2014-2016: continuing missed intervention opportunitiesAnne C Moorman, Jian Xing, Loralee B Rupp, et al.
Vaccine|October 22, 2011
Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilitiesRania A Tohme, Debo Awosika-Olumo, Carrie Nielsen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2021
The Persistence of Underreporting of Hepatitis C as an Underlying or Contributing Cause of Death, 2011-2017Philip R Spradling, Yuna Zhong, Anne C Moorman, et al.
Pageof 9